Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine M Slover

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Annals of Pharmacotherapy|May 24, 2007
Tigecycline: a novel broad-spectrum antimicrobialChristine M Slover, Keith A Rodvold, Larry H Danziger
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|August 2, 2023
Cefiderocol For Injection: Compatibility Testing Using the MINI-BAG Plus Container System and the VIAL-MATE AdaptorDhaval Rathod, Zhengming Chen, Christine M Slover, et al.
Antibiotics (Basel, Switzerland)|July 19, 2020
Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and ThriveM Courtney Safir, Sujata M Bhavnani, Christine M Slover, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2023
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use ProgramMichael J Satlin, Patricia J Simner, Christine M Slover, et al.
Microbiology Spectrum|November 15, 2023
Heteroresistance to cefiderocol in carbapenem-resistant <i>Acinetobacter baumannii</i> in the CREDIBLE-CR study was not linked to clinical outcomes: a <i>post hoc</i> analysisChristopher Longshaw, Anne Santerre Henriksen, Dana Dressel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Annals of Pharmacotherapy|May 24, 2007
Tigecycline: a novel broad-spectrum antimicrobialChristine M Slover, Keith A Rodvold, Larry H Danziger
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|August 2, 2023
Cefiderocol For Injection: Compatibility Testing Using the MINI-BAG Plus Container System and the VIAL-MATE AdaptorDhaval Rathod, Zhengming Chen, Christine M Slover, et al.
Antibiotics (Basel, Switzerland)|July 19, 2020
Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and ThriveM Courtney Safir, Sujata M Bhavnani, Christine M Slover, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2023
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use ProgramMichael J Satlin, Patricia J Simner, Christine M Slover, et al.
Microbiology Spectrum|November 15, 2023
Heteroresistance to cefiderocol in carbapenem-resistant <i>Acinetobacter baumannii</i> in the CREDIBLE-CR study was not linked to clinical outcomes: a <i>post hoc</i> analysisChristopher Longshaw, Anne Santerre Henriksen, Dana Dressel, et al.
Pageof 1